ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,066,000 | -3.0% | 30,400 | 0.0% | 0.22% | -2.2% |
| Q1 2021 | $1,099,000 | +24.5% | 30,400 | 0.0% | 0.23% | -2.6% |
| Q4 2020 | $883,000 | -11.8% | 30,400 | -14.4% | 0.23% | -12.5% |
| Q3 2020 | $1,001,000 | -12.8% | 35,500 | 0.0% | 0.26% | -9.6% |
| Q2 2020 | $1,148,000 | -20.6% | 35,500 | 0.0% | 0.29% | -24.9% |
| Q1 2020 | $1,446,000 | -33.9% | 35,500 | 0.0% | 0.39% | -44.0% |
| Q4 2019 | $2,189,000 | -15.4% | 35,500 | 0.0% | 0.70% | -4.9% |
| Q3 2019 | $2,587,000 | +25.9% | 35,500 | +42.0% | 0.73% | +27.7% |
| Q2 2019 | $2,055,000 | +115.9% | 25,000 | +85.2% | 0.57% | +146.4% |
| Q1 2019 | $952,000 | +24.4% | 13,500 | -20.6% | 0.23% | +25.9% |
| Q4 2018 | $765,000 | -20.4% | 17,000 | 0.0% | 0.18% | -33.5% |
| Q3 2018 | $961,000 | – | 17,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |